Article Details
Retrieved on: 2022-08-17 09:14:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Citigroup lifted their target price on Unity Biotechnology from $5.00 to $8.00 and gave the stock a buy rating in a report on Monday. Six research ...
Article found on: www.etfdailynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here